Press Releases

    • April 13, 2021

    Nemaura Medical Launches BEAT®diabetes Smartphone App on Android and iOS Platforms; Begins Pilot Distribution of proBEAT™ Sensors

    Loughborough, England – April 13, 2021 (GlobeNewswire) – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical...

    Read more
    March 25, 2021

    Nemaura Medical Retains Paul Kennedy as Advisor for International Growth Opportunities and Member of the Executive Advisory Board

    Loughborough, England – March 25, 2021 (GlobeNewswire)– Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic...

    Read more
    March 11, 2021

    Nemaura Medical Announces Submission to German Authorities for Reimbursement of its Glucose Monitoring Device

    Loughborough, England, March 11, 2021 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical...

    Read more
    March 10, 2021

    Nemaura Medical to Present at Maxim Group’s Inaugural Emerging Growth Virtual Conference

    Loughborough, England, March 10, 2021 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical...

    Read more
    March 4, 2021

    Nemaura Medical Appoints Industry Veteran Alistair Longmuir as Advisor on Global Product Manufacture Strategy

    Loughborough, England, March 04, 2021 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical...

    Read more
    March 3, 2021

    Nemaura Medical to Present at the H.C. Wainwright Global Life Sciences Conference

    Loughborough, England – March 3, 2021 (GlobeNewswire) – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical...

    Read more
    February 5, 2021

    Nemaura Medical Appoints Thomas Mortensen as Head of E.U. Commercial Operations and Marketing

    Loughborough, England – February 4, 2021 (GlobeNewswire) – Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical...

    Read more
    February 1, 2021

    Nemaura Medical Appoints Jay L. Warner as Head of U.S. Commercial Operations

    Loughborough, England – February 1, 2021 (GlobeNewswire) – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical...

    Read more
    December 17, 2020

    Nemaura Medical Launches BEAT®diabetes Program and Its Novel proBEAT™ Non-Invasive, Daily-Wear Adhesive Glucose Monitor

    Loughborough, England – December 17, 2020 (GlobeNewswire) – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical...

    Read more
    November 17, 2020

    Nemaura Medical Launches BEAT™diabetes Program Through New Web Presence and Re-Launches Enhanced Corporate Website

    Loughborough, England – November 17, 2020 (GlobeNewswire) – Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology...

    Read more